Osteoarthritis of the Shoulder
23
2
6
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
8.7%
2 terminated out of 23 trials
81.8%
-4.7% vs benchmark
13%
3 trials in Phase 3/4
44%
4 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (23)
TITAN™ Reverse Shoulder System
Pyrocarbon Clinical Follow-up Study
Database Retrieval for the Comprehensive Shoulder
Comprehensive Reverse Shoulder Data Collection
Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
Comparing Platelet Rich Plasma and Corticosteroid for Military & Civilian Patients With Glenohumeral Osteoarthritis
Unravelling the Etiology of Shoulder Osteoarthritis
Patients Experiences of Rehabilitation Before and After Reverse Shoulder Arthroplasty
Clinical Results and RSA Migration Analysis of the GLOBAL ICON - Stemless Anatomic Shoulder
TSA vs RSA in Glenohumeral Osteoarthritis
Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant
Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip
Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis
LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs
Clinical Experience With the Zimmer Trabecular Metal (TM) Glenoid in Total Shoulder Arthroplasty
Effectiveness of HILT in Shoulder Osteoarthritis
Improving Pain Management After Total Shoulder Replacement Using Bupivacaine Liposome
Amnion-Based Injections in the Shoulder
SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder
Reverse Shoulder Arthroplasty With or Without Concomitant Latissimus and Teres Major Transfer for Shoulder Pseudoparalysis With Teres Minor Dysfunction